Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
7.82
-0.14 (-1.76%)
At close: Feb 12, 2025, 4:00 PM
7.70
-0.12 (-1.49%)
After-hours: Feb 12, 2025, 7:16 PM EST

Amneal Pharmaceuticals Statistics

Total Valuation

AMRX has a market cap or net worth of $2.42 billion. The enterprise value is $4.99 billion.

Market Cap 2.42B
Enterprise Value 4.99B

Important Dates

The next confirmed earnings date is Friday, February 28, 2025, before market open.

Earnings Date Feb 28, 2025
Ex-Dividend Date n/a

Share Statistics

AMRX has 309.84 million shares outstanding. The number of shares has increased by 88.69% in one year.

Current Share Class 309.84M
Shares Outstanding 309.84M
Shares Change (YoY) +88.69%
Shares Change (QoQ) -2.92%
Owned by Insiders (%) 50.56%
Owned by Institutions (%) 38.81%
Float 151.47M

Valuation Ratios

PE Ratio n/a
Forward PE 11.77
PS Ratio 0.85
Forward PS 0.84
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio 9.21
P/OCF Ratio 7.75
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.81, with an EV/FCF ratio of 18.96.

EV / Earnings n/a
EV / Sales 1.86
EV / EBITDA 8.81
EV / EBIT 14.69
EV / FCF 18.96

Financial Position

The company has a current ratio of 1.38

Current Ratio 1.38
Quick Ratio 0.79
Debt / Equity n/a
Debt / EBITDA 4.50
Debt / FCF 10.05
Interest Coverage 1.32

Financial Efficiency

Return on equity (ROE) is -185.77% and return on invested capital (ROIC) is 7.57%.

Return on Equity (ROE) -185.77%
Return on Assets (ROA) 5.94%
Return on Invested Capital (ROIC) 7.57%
Return on Capital Employed (ROCE) 14.36%
Revenue Per Employee $341,455
Profits Per Employee -$23,497
Employee Count 7,850
Asset Turnover 0.75
Inventory Turnover 2.90

Taxes

In the past 12 months, AMRX has paid $23.32 million in taxes.

Income Tax 23.32M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +40.40% in the last 52 weeks. The beta is 1.10, so AMRX's price volatility has been similar to the market average.

Beta (5Y) 1.10
52-Week Price Change +40.40%
50-Day Moving Average 8.13
200-Day Moving Average 7.79
Relative Strength Index (RSI) 39.02
Average Volume (20 Days) 1,225,886

Short Selling Information

The latest short interest is 2.42 million, so 0.78% of the outstanding shares have been sold short.

Short Interest 2.42M
Short Previous Month 3.30M
Short % of Shares Out 0.78%
Short % of Float 1.60%
Short Ratio (days to cover) 2.05

Income Statement

In the last 12 months, AMRX had revenue of $2.68 billion and -$184.45 million in losses. Loss per share was -$0.63.

Revenue 2.68B
Gross Profit 979.05M
Operating Income 339.77M
Pretax Income -157.04M
Net Income -184.45M
EBITDA 566.76M
EBIT 339.77M
Loss Per Share -$0.63
Full Income Statement

Balance Sheet

The company has $77.26 million in cash and $2.64 billion in debt, giving a net cash position of -$2.57 billion or -$8.29 per share.

Cash & Cash Equivalents 77.26M
Total Debt 2.64B
Net Cash -2.57B
Net Cash Per Share -$8.29
Equity (Book Value) -33.68M
Book Value Per Share -0.30
Working Capital 418.09M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $312.84 million and capital expenditures -$49.67 million, giving a free cash flow of $263.18 million.

Operating Cash Flow 312.84M
Capital Expenditures -49.67M
Free Cash Flow 263.18M
FCF Per Share $0.85
Full Cash Flow Statement

Margins

Gross margin is 36.53%, with operating and profit margins of 12.68% and -6.88%.

Gross Margin 36.53%
Operating Margin 12.68%
Pretax Margin -4.59%
Profit Margin -6.88%
EBITDA Margin 21.14%
EBIT Margin 12.68%
FCF Margin 9.82%

Dividends & Yields

AMRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -88.69%
Shareholder Yield -88.69%
Earnings Yield -7.61%
FCF Yield 10.86%
Dividend Details

Analyst Forecast

The average price target for AMRX is $10.00, which is 27.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 27.88%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AMRX has an Altman Z-Score of 1.32 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.32
Piotroski F-Score 6